This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula (1), or a salt thereof, wherein Q, R
1
, R
2
, R
3
and R
4
are as defined herein.
US9670183B2
申请人:——
公开号:US9670183B2
公开(公告)日:2017-06-06
US9926297B2
申请人:——
公开号:US9926297B2
公开(公告)日:2018-03-27
[EN] BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR AGONISTS<br/>[FR] COMPOSÉS AZA BICYCLIQUES EN TANT QU'AGONISTES DU RÉCEPTEUR MUSCARINIQUE M1.